DNLI secures FDA nod for Avlayah, a first-in-decades Hunter syndrome therapy, but pipeline risks and Takedas exit complicate ...
A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...
A woman in her 50s with genetically confirmed Huntington’s disease presented with right-sided arm sensory symptoms that evolved over days and persisted for at least 1 month. Neurological examination ...
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees. On April 14, 2026, the Compensation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results